Pharmaceutical

Lexicon partners Viatris for global expansion of sotagliflozin

Lexicon Pharmaceuticals has entered a licensing agreement with Viatris to commercialise sotagliflozin outside the US and Europe.

Oct 18, 2024 - 04:00
Lexicon partners Viatris for global expansion of sotagliflozin
Lexicon Pharmaceuticals has entered a licensing agreement with Viatris to commercialise sotagliflozin outside the US and Europe.
Read the original article

Tags:

Previous Article

Health Canada approves Acadia’s DAYBUE for Rett syndrome

Next Article

J&J trims neuroscience pipeline – seltorexant in Alzheimer’s disease dropped 

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Sales of antibiotics for food-producing animals dropped by more than half in Europe over the past decade

STAT+: Sales of antibiotics for food-producing animals ...

Nov 27, 2023

Morning Rounds: 3D-printed organs, antimicrobial resistance in Ukraine, and other major health stories of the day

Morning Rounds: 3D-printed organs, antimicrobial resist...

Dec 9, 2023

STAT+: Pharmalittle: Bluebird’s sickle-cell screwups may prompt a sale; drugmakers raised prices on widely used meds without new clinical evidence

STAT+: Pharmalittle: Bluebird’s sickle-cell screwups ma...

Dec 11, 2023